Browse the complete Report on: What's Next in Vaccines? HIV, Malaria, Rabies, MRSA, and 30 Other Vaccine Targets in the 2010-2020 Pipeline

Browse All Kalorama Information Reports at Kalorama Information

The global market for human vaccines has experienced strong growth in the past few years, and R&D departments at many pharmaceutical companies are working on new prophylactics, some of which may see near-term marketing. What illnesses may see a vaccine option in the coming years? Which vaccines will have the most successful business model? Who are the major companies in this market, and possible new entrants? What can current vaccine success stories tell us about the future of the vaccine market? This Kalorama Information report What's Next in Vaccines?examines and estimates the market for vaccines that have yet to be launched, including the following target areas:

• Addiction

• Allergy

• Alzheimer’s Disease

• Anthrax

• Asthma

• Campylobacter Infection

• Chlamydia

• Croup

• Dengue Fever

• Diabetes

• Ebola

• Epstein-Barr Virus

• Enterotoxigenic Escherichia coli

• Helicobacter Pylori

• Hepatitis

• Herpesvirus

• Hookworm

• Hypertension

• HIV/AIDS

• Leishmaniasis

• Malaria

• MRSA Infection

• Multiple Sclerosis

• Obesity

• Parainfluenza Virus Type 3

• Parkinson’s Disease

• Plague

• Respiratory Syncytial Virus

• Ross River Virus

• Shigellosis

• Smoking

• Stroke

• Tuberculosis

• West Nile Virus

Some of these vaccines may see success; some could be the blockbusters of the future. For marketers and industry watchers a knowledge of all of the potential vaccines will be important to understand how pharma is seeking to renew bottom line with aggressive prophylactic strategies, and who the winners and losers in the near future may be.

Alison Sahoo has looked at the vaccine market three times in as many years for Kalorama Information, and in this report applies a knowledge of what companies have done in the past to potential efforts.

There are a number of trends that will impact the industry that market watchers will want to know about, and Kalorama Information has covered these trends; including: New Vaccine Technologies, DNA Vaccination, Innovative Delivery Systems, Edible Vaccines, Vaccine Patches, Funding Shortfalls. The report also discusses vaccine manufacturing methods and the approval process. In addition, the report focuses on the emerging vaccine activities of the following companies

• 
  Acambis plc
• ACE BioSciences

• AFFiRiS

• ALK-Abello A/S

• Allergy Therapeutics

• Bavarian Nordic A/S

• Baxter Healthcare

• Celldex Therapeutics

• Crucell

• Cytos Biotechnology Financial GlaxoSmithKline

• Hawaii Biotech

• Intercell

• Medimmune

• Merck & Co. Inc

• Mymetics

• Nabi Biopharmaceuticals

• Novartis

• Opexa Therapeutics

• Paladin Labs

• Sanofi Pasteur

This report provides forecasted revenues for products in development out to 2020. The report does not does not cover indication expansions of existing vaccine products, nor does it cover vaccines for which products currently exist and are widely available, but may need improvement. Development of vaccines that incorporate new

production methods (such as the migration of chicken eggs to mammal, yeast or other cells) is also excluded. Cancer vaccines are excluded as Kalorama has an entire report on this topic.

Sales estimates for each market segment represent global revenues and are expressed in current dollars. Information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources.

About Us
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Contact: 

Ms. Sunita

7557 Rambler road,

Suite 727, Dallas, TX 75231

Tel: +1-888-989-8004

http://reportsandreports.blogspot.com/ 

http://reportsandreports.proarticles.co.uk/ 

http://reportsnreports.wordpress.com/

Browse the complete Report on: SNP Genotyping and Analysis Markets

Browse All Kalorama Information Reports at Kalorama Information

Because SNPs (single nucleotide polymorphisms),are the most common type of genetic variation between human beings. These single base pair mutations at specific DNA sequence sites, can be ideal for the task of hunting for correlations between genotype and behavior or quality exhibited by a living organism.

The use of SNP analysis has spread into numerous areas in recent years. But diagnostics and pharmacogenomics are the most promising applications, and market watchers in diagnostics, pharmaceutical, biotechnology and related instrument industries will want to watch developments in SNP analysis closely.

Kalorama Information's analyst Justin Saeks has taken a detailed look into the market for DNA Sequencing Equipment, as well as Gene Expression Profiling Systems. Now, in His report SNP Genotyping and Analysis Markets he looks at SNP analysis instruments, reagents, and related software and services, providing information critical to having an understanding of the business behind this new technology:

• Overview of SNPs, their Applications and Key SNP Analysis Methods 

• Current Market Size and Estimates of Future Growth 

• Impact of the GWAS 'First Round'on the Market 

• Estimates of Revenues by Region (North America, Europe and ROW) and By Product Type (Consumable, Instruments, Software) 

• Complete List ofSNP-Related Deals Made Between Companies Since 2002 

• Exhaustive Review of Products on the Market 

• Market Share of Major Companies in SNP Analysis 

• Discussion of GOLD Database Projects, Government Involvement and Funding 

• Corporate Profiles 

• Regulatory, Technology and Industry Trends as well as; 

• Twelve Challengesthe Market Faces andEight Strategic Recommendationsfor Companies in the SNP Analysis Market

While the market is expected to create opportunities for growth, the SNP Genotyping and Analysis market is not without its challenges. The report tackles the following trends:

• Rapid Rate of Product Introductions

• Increased Multiplexing Creates Improved Products

• End-Users Attracted to Larger-Scale SNP Platforms

• Accelerating Discoveries Create Volatile Market

• Diagnostic Market Holds Obstacles For New Innovations

• Complexity of Biological Systems Requires Multiple Techniques

• Miniaturization of Equipment and Instruments

As with all Kalorama Information publications, SNP Genotyping and Analysis Markets is the result of a primary research effort. An analyst with experience following the biotech instrument industry researching all available sources and contacting industry experts and end users to obtain real market insights. Strategic Planners, Marketing Directors, Business Development Executives are among the individuals who will benefit from this resource.

About Us
ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

Contact: 

Ms. Sunita

7557 Rambler road,

Suite 727, Dallas, TX 75231

Tel: +1-888-989-8004

http://reportsandreports.blogspot.com/ 

http://reportsandreports.proarticles.co.uk/ 

http://reportsnreports.wordpress.com/